BACKGROUND: The dose of mifepristone approved by most government agencies for
medical abortion is 600 mg. Our aim was to summarize extant data on the effectiveness and …

OBJECTIVE: To estimate the efficacy and acceptability of medical abortion at 64–70 days
from last menstrual period (LMP) and to compare it with the already proven 57–63 days from …

Medication abortion (also commonly referred to as medi cal abortion) is arguably the most
important advance in reproductive health technology since the discovery of oral …

This article presents the findings of a qualitative study exploring the experiences of women
living in Buenos Aires Metropolitan Area, Argentina, with the use of misoprostol for inducing …

Abstract Background Abortion rates in Latin America and the Caribbean (LAC) are nearly
triple those in Western Europe, due to less use of contraception and highly restrictive …

BACKGROUND: Most medical abortion protocols require women to take mifepristone in the
doctor's office. We assessed the acceptability of home use of mifepristone among women …

Introduction: Disrespect and abuse is a component of poor quality of abortion care. This
analysis aimed to understand negative experiences of care from perspectives of abortion …

Abstract 'Body work'has emerged at the nexus of sociologies of work and bodies as a means
of conceptualising work focusing on the bodies of others. This article utilises this analytical …

Aims and objectives To improve the understanding and competence of health personnel
when caring for ambivalent pregnant women, the aim of this study was to explore the …

Objectives The objective of this study was to evaluate a person-centered abortion care
mobile-based intervention on perceived social stigma, social support, mental health and …